You are here

Novartis

Novartis touts latest Zolgensma data as SMA competition against Biogen, Roche heats up

Fierce Pharma

Sun, 06/20/21 - 10:21 pm

spinal muscular atrophy

Novartis sets the tone for the radiopharma push with a prized acquisition winning breakthrough therapy designation

Endpoints

Thu, 06/17/21 - 11:09 am

radiopharmaceuticals

breakthrough therapy

The big approvals still on the cards for 2021

EP Vantage

Thu, 06/17/21 - 11:00 am

Ascendis Pharma

Axsome Therapeutics

Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen

Fierce Pharma

Tue, 06/15/21 - 11:41 pm

EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH

Pharmaforum

Sat, 06/12/21 - 10:26 pm

clinical trials

BMS will file for earlier-line use of Breyanzi in lymphoma after trial win

Pharmaforum

Fri, 06/11/21 - 10:49 am

Bristol Myers Squibb

large B-cell lymphoma

Gilead Sciences

Novartis extends operations at U.K. plant for another year, keeping some 200 workers on board

Fierce Pharma

Wed, 06/9/21 - 10:55 pm

drug manufacturing

Novartis’ $2 Million Gene Therapy Zolgensma Shows ‘Remarkable’ Results and Offers Hope for Children with SMA

Xtalks

Tue, 06/8/21 - 12:19 pm

Roche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey

Fierce Pharma

Mon, 06/7/21 - 08:29 pm

Under ‘threat’ of fines, Novartis sues HHS over drug pricing program

Endpoints

Mon, 06/7/21 - 11:14 am

#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle

Endpoints

Thu, 06/3/21 - 10:51 am

follicular lymphoma

Gilead Sciences

Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment

Biopharma Reporter

Thu, 06/3/21 - 12:11 am

Molecular Partners

clinical trials

#ASCO21: Novartis keeps building out survival data for Kisqali, hoping to keep the pressure on Pfizer's Ibrance

Endpoints

Thu, 06/3/21 - 12:09 am

GlaxoSmithKline scores a big win in Zofran litigation after FDA repeatedly rejects pregnancy warning

Fierce Pharma

Wed, 06/2/21 - 11:04 am

Novartis stakes another PhIII win for Cosentyx, goes deeper into pediatric markets

Endpoints

Wed, 06/2/21 - 10:54 am

juvenile idiopathic arthritis

Novartis plots 'next frontier' of MS treatment — and it could spell a buyout for a small Swiss player

Endpoints

Tue, 06/1/21 - 11:10 am

multiple sclerosis

Novartis halts three trials of Beovu eye drug on safety concerns

Pharmaforum

Tue, 06/1/21 - 11:03 am

clinical trials

wet age-related macular degeneration

Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech

Fierce Biotech

Wed, 05/19/21 - 10:31 am

Tevard Biosciences

Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe

Fierce Pharma

Tue, 05/18/21 - 11:01 am

drug manufacturing

Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein

Fierce Pharma

Mon, 05/17/21 - 10:59 pm

Pages